Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants

The present study characterizes the relationship between the endogenous mu opioid peptides endomorphin‐1 (EM‐1) and endomorphin‐2 (EM‐2) and several splice variants of the cloned mu opioid receptor (MOR‐1) encoded by the mu opioid receptor gene (Oprm). Confocal laser microscopy revealed that fibers containing EM‐2‐like immunoreactivity (‐LI) were distributed in close apposition to fibers showing MOR‐1‐LI (exon 4‐LI) and to MOR‐1C‐LI (exons 7/8/9‐LI) in the superficial laminae of the lumbar spinal cord. We also observed colocalization of EM‐2‐LI and MOR‐1‐LI in a few fibers of lamina II, and colocalization of EM‐2‐LI and MOR‐1C‐LI in laminae I–II, and V–VI. To assess the functional relevance of the MOR‐1 variants in endomorphin analgesia, we examined the effects of antisense treatments that targeted individual exons within the Oprm1 gene on EM‐1 and EM‐2 analgesia in the tail flick test. This antisense mapping study implied mu opioid receptor mechanisms for the endomorphins are distinct from those of morphine or morphine‐6β‐glucuronide (M6G).

[1]  Stanley J. Watson,et al.  Cloning and pharmacological characterization of a rat μ opioid receptor , 1993, Neuron.

[2]  G. Pasternak,et al.  Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. , 1997, The Journal of pharmacology and experimental therapeutics.

[3]  G. Uhl,et al.  mu opiate receptor: cDNA cloning and expression. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Hsu,et al.  Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. , 1998, Circulation.

[5]  G. Pasternak,et al.  Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. , 1999, Molecular pharmacology.

[6]  R. Przewłocki,et al.  Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. , 1999, European journal of pharmacology.

[7]  G. Pasternak,et al.  Comparative immunohistochemical distributions of carboxy terminus epitopes from the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS , 2000, Neuroscience.

[8]  A. Zimprich,et al.  Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1 , 1995, FEBS letters.

[9]  L. Stone,et al.  Spinal analgesic actions of the new endogenous opioid peptides endomorphin‐1 and ‐2 , 1997, Neuroreport.

[10]  A. Kastin,et al.  Localization of Endomorphin-2-Like Immunoreactivity in the Rat Medulla and Spinal Cord , 1997, Peptides.

[11]  H. Loh,et al.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  M. Wessendorf,et al.  Immunoreactivity for endomorphin‐2 occurs in primary afferents in rats and monkey , 1998, Neuroreport.

[13]  G. Pasternak,et al.  Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[14]  Lei Yu,et al.  Molecular cloning and functional expression of a mu opioid receptor from rat brain , 1994, Regulatory Peptides.

[15]  A. Kastin,et al.  Endomorphin-2 is an endogenous opioid in primary sensory afferent fibers , 1998, Peptides.

[16]  L. Bare,et al.  Expression of two variants of the human μ opioid receptor mRNA in SK‐N‐SH cells and human brain , 1994, FEBS letters.

[17]  R M Eglen,et al.  7TM receptors: the splicing on the cake. , 1999, Trends in pharmacological sciences.

[18]  T. Pierce,et al.  Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain , 2000, Journal of Chemical Neuroanatomy.

[19]  S. Schulz,et al.  Immunofluorescent identification of endomorphin‐2‐containing nerve fibers and terminals in the rat brain and spinal cord , 1998, Neuroreport.

[20]  Z. Wiesenfeld‐Hallin,et al.  The effect of intrathecal endomorphin-2 on the flexor reflex in normal, inflamed and axotomized rats: reduced effect in rats with autotomy , 2000, Neuroscience.

[21]  H. Ueda,et al.  Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. , 1999, European journal of pharmacology.

[22]  A. Vaccarino,et al.  Analgesic effects of endomorphin-1 and endomorphin-2 in the formalin test in mice. , 2000, Life sciences.

[23]  P. Sánchez-Blázquez,et al.  Antisense oligodeoxynucleotide targeting distinct exons of the cloned mu-opioid receptor distinguish between endomorphin-1 and morphine supraspinal antinociception in mice. , 1999, Antisense & nucleic acid drug development.

[24]  T. Kaneko,et al.  Immunohistochemical localization of μ‐opioid receptors in the central nervous system of the rat , 1996, The Journal of comparative neurology.

[25]  G. Pasternak,et al.  Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Pasternak Incomplete cross tolerance and multiple mu opioid peptide receptors. , 2001, Trends in pharmacological sciences.

[27]  G. Pasternak,et al.  Antisense mapping the MOR‐1 opioid receptor: evidence for alternative splicing and a novel morphine‐6β‐glucuronide receptor , 1995, FEBS letters.

[28]  G. Pasternak,et al.  Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. , 1995, Trends in pharmacological sciences.

[29]  C. Chen,et al.  Immunolabeling of mu opioid receptors in the rat nucleus of the solitary tract: extrasynaptic plasmalemmal localization and association with Leu5‐enkephalin , 1996, The Journal of comparative neurology.

[30]  Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR‐IC within the human spinal cord , 2000, Neuroreport.

[31]  M. Szikszay,et al.  Antinociceptive effects of intrathecal endomorphin-1 and -2 in rats. , 1999, Life Science.

[32]  Á. Díaz,et al.  Distinct inhibitory effects of spinal endomorphin‐1 and endomorphin‐2 on evoked dorsal horn neuronal responses in the rat , 1997, British journal of pharmacology.

[33]  G. Pasternak,et al.  Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR‐1F , 2000, FEBS letters.

[34]  G. Pasternak,et al.  Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia , 1996, Neuroscience Letters.

[35]  V. Pickel,et al.  Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  V. Pickel,et al.  Ultrastructural localization of μ-opioid receptors in the superficial layers of the rat cervical spinal cord: extrasynaptic localization and proximity to Leu5-enkephalin , 1996, Brain Research.

[37]  A. Hsu,et al.  Ischemic Preconditioning in the Intact Rat Heart Is Mediated by δ1- But Not μ- or κ-Opioid Receptors , 1998 .

[38]  J. Kampine,et al.  Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. , 2000, The Journal of pharmacology and experimental therapeutics.

[39]  A I Basbaum,et al.  Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[40]  G. Pasternak,et al.  Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR‐1C‐like and MOR‐1‐like immunoreactivity: Evidence for region‐specific processing , 2000, The Journal of comparative neurology.

[41]  A. Kastin,et al.  A potent and selective endogenous agonist for the µ-opiate receptor , 1997, Nature.